Cancer Survivors Face Substantial Medical Financial Hardship By Jo CavalloPosted: 1/15/2020 10:04:00 AM Last Updated: 1/16/2020 4:30:07 PM Although advances in cancer treatments have led to huge increases in the number of survivors in the United States—more than 16.9 million in 2019—many of those…
Researchers explored the potential benefits of a higher dosage of radioembolization treatment using yttrium (Y)-90 microspheres in patients with hepatocellular carcinoma.
Researchers have identified genetic risk factors that may contribute to prostate cancer in a diverse group of African men.
In a study published as a research letter in JAMA Oncology, Cederquist et al found that patients with breast cancer who received adjuvant radiation therapy…
Updated results of a Swedish screening study (GOTEBORG-2), reported in The New England Journal of Medicine by Hugosson et al, indicate that omitting biopsy among…
The phase III KEYNOTE-A18 trial, presented at the European Society for Medical Oncology (ESMO) Congress 2024, found that treatment with the PD-1 inhibitor pembrolizumab plus…
Researchers at Case Western Reserve University and Vanderbilt University have received a $3.7 million grant from the National Cancer Institute to pioneer a novel approach…
Despite considerable progress in the discovery and development of new cancer drugs between 1990 and 2022, there may be disparities in both the availability and…
In a Chinese phase II trial (INOVA) reported in The Lancet Oncology, Peng et al evaluated the combination of sintilimab and bevacizumab in patients with…
“Three years ago, it had become clear that I needed to be tested for the BRCA1/2 mutation. I knew my family history of cancer was…
Ann Partridge, MD, MPH, of Dana-Farber Cancer Institute, was named the recipient of the 2024 ESMO Award during the opening session of the European Society…
